• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5 期慢性肾脏病的生物标志物分析确定了血管生成素-2 与心房颤动之间的关系。

Biomarker Profiling in Stage 5 Chronic Kidney Disease Identifies the Relationship between Angiopoietin-2 and Atrial Fibrillation.

机构信息

Department of Pathology, Loyola University Medical Center, Maywood, IL, USA.

Department of Nephrology, Loyola University Medical Center, Maywood, IL, USA.

出版信息

Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):269S-276S. doi: 10.1177/1076029618808909. Epub 2018 Oct 28.

DOI:10.1177/1076029618808909
PMID:30370780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6707900/
Abstract

Atrial fibrillation (AF) is prevalent in nearly 27% of patients with stage 5 chronic kidney disease on hemodialysis (CKD5-HD), suggesting a strong association between these 2 pathologies. It is hypothesized that the relationship between these 2 diseases may be mediated by inflammation. Angiopoietin-2 (Ang-2), a pro-inflammatory biomarker of endothelial instability, inflammation, and vascular remodeling, is elevated in CKD5-HD and AF, yet has not been evaluated in patients with concomitant AF and CKD5-HD. The aim of this study is to analyze circulating levels of inflammatory and thrombotic biomarkers in patients with concomitant AF and CKD5-HD. Plasma levels of Ang-2 were measured via sandwich enzyme-linked immunosorbent assay method in CKD5-HD patients (n = 96), patients with AF (n = 38), and controls (n = 50). Angiopoietin-2 was markedly elevated in CKD5-HD with comorbid AF as compared to CKD5-HD alone, and AF alone, respectively (13.05 ± 1.56 vs 9.57 ± 0.71 ng/mL; = .00169; vs 2.48 ± 0.57 ng/mL; < .0001). The results of this study suggest an additive effect of Ang-2 with coexistence of AF and CKD5-HD, which may be useful in the detection of AF within this patient population.

摘要

心房颤动(AF)在接受血液透析(CKD5-HD)的 5 期慢性肾脏病(CKD5-HD)患者中患病率接近 27%,提示这两种病理之间存在很强的关联。据推测,这两种疾病之间的关系可能通过炎症来介导。血管生成素-2(Ang-2)是内皮不稳定、炎症和血管重塑的促炎生物标志物,在 CKD5-HD 和 AF 中升高,但在同时患有 AF 和 CKD5-HD 的患者中尚未得到评估。本研究旨在分析同时患有 AF 和 CKD5-HD 的患者循环中炎症和血栓形成生物标志物的水平。通过夹心酶联免疫吸附测定法测量了 CKD5-HD 患者(n=96)、AF 患者(n=38)和对照组(n=50)的血浆 Ang-2 水平。与单独 CKD5-HD 相比,同时患有 AF 和 CKD5-HD 的患者的 Ang-2 水平明显升高,分别为(13.05±1.56)ng/mL 比(9.57±0.71)ng/mL( =.00169);与单独 AF 相比,分别为(13.05±1.56)ng/mL 比(2.48±0.57)ng/mL( <.0001)。这项研究的结果表明,AF 与 CKD5-HD 共存时存在 Ang-2 的附加效应,这可能有助于在该患者人群中检测 AF。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5894/6714826/a0656c5b8f2e/10.1177_1076029618808909-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5894/6714826/a0656c5b8f2e/10.1177_1076029618808909-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5894/6714826/a0656c5b8f2e/10.1177_1076029618808909-fig1.jpg

相似文献

1
Biomarker Profiling in Stage 5 Chronic Kidney Disease Identifies the Relationship between Angiopoietin-2 and Atrial Fibrillation.5 期慢性肾脏病的生物标志物分析确定了血管生成素-2 与心房颤动之间的关系。
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):269S-276S. doi: 10.1177/1076029618808909. Epub 2018 Oct 28.
2
Procalcitonin as a Marker of Comorbid Atrial Fibrillation in Chronic Kidney Disease and History of Sepsis.降钙素原作为慢性肾脏病合并房颤和脓毒症病史的标志物。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620932228. doi: 10.1177/1076029620932228.
3
Elevated extracellular nucleosomes and their relevance to inflammation in stage 5 chronic kidney disease.细胞外核小体水平升高及其与5期慢性肾脏病炎症的相关性。
Int Angiol. 2018 Oct;37(5):419-426. doi: 10.23736/S0392-9590.18.03987-1. Epub 2018 Apr 11.
4
Biomarkers of Endothelial, Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure.5期慢性肾脏病心力衰竭血液透析患者内皮、肾脏及血小板功能障碍的生物标志物
Clin Appl Thromb Hemost. 2018 Mar;24(2):235-240. doi: 10.1177/1076029617729216. Epub 2017 Oct 8.
5
Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.从过渡到肾脏替代治疗看内皮功能障碍和低度炎症。
PLoS One. 2019 Sep 13;14(9):e0222547. doi: 10.1371/journal.pone.0222547. eCollection 2019.
6
Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.血管生成素2与透析及肾移植中的心血管疾病
Am J Kidney Dis. 2009 May;53(5):770-8. doi: 10.1053/j.ajkd.2008.11.030. Epub 2009 Mar 5.
7
Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?可溶性CD40配体与心房颤动中血管内皮生长因子、血管生成素及组织因子的关系:血小板活化、血管生成与血栓形成之间的联系?
Chest. 2007 Dec;132(6):1913-9. doi: 10.1378/chest.07-1565.
8
Osteopontin Levels in Patients With Chronic Kidney Disease Stage 5 on Hemodialysis Directly Correlate With Intact Parathyroid Hormone and Alkaline Phosphatase.骨桥蛋白水平与慢性肾脏病 5 期血液透析患者的甲状旁腺激素和碱性磷酸酶直接相关。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619896621. doi: 10.1177/1076029619896621.
9
Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.血浆戊糖苷及其与慢性肾脏病患者死亡率的关联。
PLoS One. 2016 Oct 4;11(10):e0163826. doi: 10.1371/journal.pone.0163826. eCollection 2016.
10
Markers of endothelial damage in patients with chronic kidney disease on hemodialysis.慢性肾脏病血液透析患者的内皮损伤标志物。
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F673-F681. doi: 10.1152/ajprenal.00013.2016. Epub 2017 Jan 11.

引用本文的文献

1
Exploring Angiopoietin-2: Clinical Insights and Experimental Perspectives in Kidney Diseases.探索血管生成素-2:肾脏疾病的临床见解与实验展望
Kidney Int Rep. 2024 Sep 6;9(12):3375-3385. doi: 10.1016/j.ekir.2024.09.001. eCollection 2024 Dec.
2
Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study.基于生物标志物预测心房颤动患者的窦性心律:EAST-AFNET 4生物分子研究
Eur Heart J. 2024 Dec 16;45(47):5002-5019. doi: 10.1093/eurheartj/ehae611.
3
Angiopoietin-2 and Angiopoietin-like Proteins with a Prospective Role in Predicting Diabetic Nephropathy.

本文引用的文献

1
Von Willebrand Factor: Multimeric Structure and Functional Activity in Patients With Atrial Fibrillation With and Without Oral Anticoagulation.血管性血友病因子:伴有或不伴有口服抗凝治疗的心房颤动患者的多聚体结构与功能活性
Clin Appl Thromb Hemost. 2018 May;24(4):647-654. doi: 10.1177/1076029617711803. Epub 2017 Jun 15.
2
The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.心房颤动与慢性肾脏病的关系:两种流行病的流行病学和病理生理学考量
J Atr Fibrillation. 2012 Jun 15;5(1):442. doi: 10.4022/jafib.442. eCollection 2012 Jun-Jul.
3
血管生成素-2和血管生成素样蛋白在预测糖尿病肾病中的前瞻性作用
Biomedicines. 2024 Apr 24;12(5):949. doi: 10.3390/biomedicines12050949.
4
Myocardial Oedema as a Consequence of Viral Infection and Persistence-A Narrative Review with Focus on COVID-19 and Post COVID Sequelae.心肌水肿作为病毒感染和持续存在的后果——以 COVID-19 和新冠后遗症为重点的叙述性综述。
Viruses. 2024 Jan 14;16(1):121. doi: 10.3390/v16010121.
5
Serum Angiopoietin-2 level increase differs between polytraumatized patients with and without central nervous system injuries.血清血管生成素-2 水平的增加在合并与不合并中枢神经系统损伤的多发伤患者中有所不同。
Sci Rep. 2023 Nov 7;13(1):19338. doi: 10.1038/s41598-023-45688-x.
6
High Plasma Angiopoietin-2 Levels Predict the Need to Initiate Dialysis within Two Years in Patients with Chronic Kidney Disease.高血浆血管生成素-2 水平可预测慢性肾脏病患者在两年内需要开始透析。
Int J Mol Sci. 2023 Jun 12;24(12):10036. doi: 10.3390/ijms241210036.
7
The association of coagulation and atrial fibrillation: a systematic review and meta-analysis.凝血与心房颤动的关联:系统评价和荟萃分析。
Europace. 2023 Feb 8;25(1):28-39. doi: 10.1093/europace/euac130.
8
Cross-reaction between mouse and rat immunoglobulin G: does it matter in sandwich ELISA?小鼠和大鼠免疫球蛋白G之间的交叉反应:在夹心酶联免疫吸附测定中这重要吗?
J Genet Eng Biotechnol. 2021 Aug 17;19(1):119. doi: 10.1186/s43141-021-00222-2.
9
Procalcitonin as a Marker of Comorbid Atrial Fibrillation in Chronic Kidney Disease and History of Sepsis.降钙素原作为慢性肾脏病合并房颤和脓毒症病史的标志物。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620932228. doi: 10.1177/1076029620932228.
Biomarkers and the prediction of atrial fibrillation: state of the art.
生物标志物与心房颤动的预测:当前技术水平
Vasc Health Risk Manag. 2016 Jul 18;12:297-303. doi: 10.2147/VHRM.S75537. eCollection 2016.
4
Chronic Kidney Disease and the Risk of New-Onset Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies.慢性肾脏病与新发心房颤动风险:前瞻性队列研究的荟萃分析
PLoS One. 2016 May 13;11(5):e0155581. doi: 10.1371/journal.pone.0155581. eCollection 2016.
5
Prediction of atrial fibrillation development and progression: Current perspectives.心房颤动发生与进展的预测:当前观点
World J Cardiol. 2016 Mar 26;8(3):267-76. doi: 10.4330/wjc.v8.i3.267.
6
Inflammation and the pathogenesis of atrial fibrillation.炎症与心房颤动的发病机制。
Nat Rev Cardiol. 2015 Apr;12(4):230-43. doi: 10.1038/nrcardio.2015.2. Epub 2015 Jan 27.
7
The inflammatory response in myocardial injury, repair, and remodelling.心肌损伤、修复及重塑中的炎症反应。
Nat Rev Cardiol. 2014 May;11(5):255-65. doi: 10.1038/nrcardio.2014.28. Epub 2014 Mar 25.
8
Oxidative stress and atrial fibrillation: finding a missing piece to the puzzle.氧化应激与心房颤动:寻找拼图中缺失的一块。
Circulation. 2013 Oct 15;128(16):1724-6. doi: 10.1161/CIRCULATIONAHA.113.005837. Epub 2013 Sep 12.
9
Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.成人慢性肾脏病患者的阵发心房颤动与终末期肾病风险。
Circulation. 2013 Feb 5;127(5):569-74. doi: 10.1161/CIRCULATIONAHA.112.123992. Epub 2012 Dec 28.
10
Inflammation in atrial fibrillation.心房颤动中的炎症。
J Am Coll Cardiol. 2012 Dec 4;60(22):2263-70. doi: 10.1016/j.jacc.2012.04.063.